acute lymphoblastic leukemia

Research in Review

Risk Stratification, Therapy Intensification Improves Prognosis in Adult ALL

06/29/2017

JCP Editors

Adult patients with a type of acute lymphoblastic leukemia (ALL) may benefit from the use of response-based risk stratification and therapy intensification used in pediatric disease. Early thymic precursor (ETP)-ALL...

Adult...

06/29/2017

Journal of Clinical Pathways

Research in Review

Leukemia Survival Outcomes Differ Between Sites of Care

04/11/2017

JCP Editors

Sites of care may help explain survival differences between children and adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), according to research published...

Sites...

04/11/2017

Journal of Clinical Pathways

Research in Review

B-Cell ALL Disease Burden May Influence CAR T-Cell Therapy Impact on Survival

04/10/2017

JCP Editors

CD19-specific chimeric antigen receptor (CAR) T-cell therapy is more likely to be effective when given immediately after front-line therapy rather than after relapse in certain patients with B-cell acute...

...

04/10/2017

Journal of Clinical Pathways

Research in Review

New Treatment Effective for B-Cell Precursor ALL in Pediatric Patients

11/17/2016

JCP Editors

Single-agent blinatumomab demonstrated antileukemia activity in pediatric patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL), according to a study published in the Journal of...

...

11/17/2016

Journal of Clinical Pathways